HAEMONETICS CORP Earnings Per Share Diluted

• HAEMONETICS CORP showed an increase of +44.5% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from HAEMONETICS CORP's annual report (Form 10-K), filed with the SEC on May 21, 2025.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2009 to 2025), HAEMONETICS CORP's Earnings Per Share Diluted has grown by 45.8%.
• Historical annual values: Fiscal year 2025: $3.31 per share | Fiscal year 2024: $2.29 per share | Fiscal year 2023: $2.24 per share | Fiscal year 2022: $0.84 per share | Fiscal year 2021: $1.55 per share | Fiscal year 2020: $1.48 per share | Fiscal year 2019: $1.04 per share | Fiscal year 2018: $0.85 per share | Fiscal year 2017: $0.51 (loss) per share | Fiscal year 2016: $1.09 (loss) per share | Fiscal year 2015: $0.32 per share | Fiscal year 2014: $0.67 per share | Fiscal year 2013: $0.74 per share | Fiscal year 2012: $1.30 per share | Fiscal year 2011: $1.56 per share | Fiscal year 2010: $2.24 per share | Fiscal year 2009: $2.27 per share.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026